Latest news with #patentinfringement
GSM Arena
2 days ago
- Business
- GSM Arena
Samsung hit with $117M fine over patent infringement
Samsung found itself under a patent infringement case filed with the U.S. District Court in Texarkana, Texas. The court reached an early verdict and ordered Samsung to pay out $117.7 million in damages. The plaintiff? Maxell (formerly Hitachi Maxell), whose patents related to Galaxy smartphone and tablet unlocking tech, data management and smart home platforms were violated. The current case was initially filed back in September 2023 when Maxell accused Samsung of violating seven of its patents by selling a variety of products, including the SmartThings station alongside smartphones, laptops and home appliances all using Maxell's patented tech. Samsung SmartThings station According to a report shared by The Korea Herald, Samsung licensed Maxell's patents for the duration of ten years back in 2011. Once the initial agreement expired in 2021, Samsung continued using the patented tech without renegotiating its license with Maxell. The Japanese company then filed legal complaints across several district courts across the U.S, Germany and Japan. Samsung can appeal the current district court decision to a higher court, and is expected to do so, which means this legal battle is far from over. Source
Reuters
3 days ago
- Business
- Reuters
Samsung owes $112 mln for infringing Maxell patents, US jury says
May 29 (Reuters) - A federal jury in Texas has determined that Samsung Electronics ( opens new tab owes electronics maker Maxell (6810.T), opens new tab nearly $112 million after finding that the Korean tech giant's devices violate Maxell's patent rights. The jury in Texarkana, Texas, said in its verdict on Wednesday, opens new tab that Samsung's Galaxy smartphones, tablets and other devices infringe three of Japan-based Maxell's patents related to networking, information processing and other technologies. Attorneys and spokespeople for the companies did not immediately respond to requests for comment on the verdict on Thursday. The award adds to a string of recent nine-figure patent infringement verdicts against Samsung in East Texas federal court, including a $279 million verdict in a separate dispute over wireless technology last month. Maxell sued Samsung for patent infringement in 2023 over a wide range of its electronics. The complaint said that Samsung previously obtained a license to Maxell's patents that Samsung failed to renew. Samsung denied Maxell's infringement allegations and argued that the patents were invalid. Maxell requested nearly $130 million in damages, according to a court filing. The case is Maxell Ltd v. Samsung Electronics Co, U.S. District Court for the Eastern District of Texas, No. 5:23-cv-00092. For Maxell: Jamie Beaber, Alan Grimaldi, Kfir Levy, James Fussell and Robert Pluta of Mayer Brown For Samsung: Brian Erickson, Sean Cunningham, Erin Gibson, Mark Fowler and Michael Jay of DLA Piper
Yahoo
25-05-2025
- Business
- Yahoo
Tandem Diabetes and Roche Reach a Patent Settlement
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) has agreed to pay Roche $36 million to resolve a patent infringement lawsuit over Tandem's t:slim X2 insulin pump. A hospital room with a patient using a medical device to administer insulin. The deal settles all pending and prospective litigation about two European patents that Roche filed in December 2023, EP 2 196 231 B1 and EP 1 970 677 B1. Over the next four years, Tandem Diabetes Care, Inc. (NASDAQ:TNDM) will pay the remaining $28 million in four equal annual installments after making an initial payment of $8 million. Both businesses have signed a cross-license agreement as part of the settlement, which will be in place for ten years and grant each other non-exclusive, non-sublicensable, non-royalty-bearing, and irrevocable rights for patents of insulin delivery systems. This action ends all ongoing legal proceedings under the Unified Patent Court in France and Germany, including infringement, revocation, and non-infringement declarations. Tandem Diabetes Care, Inc. (NASDAQ:TNDM)'s t:slim X2 pump will remain commercially available due to the agreement, which also lowers both companies' future legal risk. While we acknowledge the potential of TNDM to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than TNDM and that has 100x upside potential, check out our report about this READ NEXT: and . Disclosure. None.
National Post
21-05-2025
- Business
- National Post
SEKISUI CHEMICAL: Victory in German Patent Infringement Lawsuit Concerning PVB Interlayer Films
Article content TOKYO — The High Performance Plastics Company (President : Akira Asano) of SEKISUI CHEMICAL CO., LTD. (President and Representative Director: Keita Kato; hereinafter 'SEKISUI CHEMICAL') hereby notifies that it has obtained judgments in its favor (hereinafter referred to as 'the Judgments') from the District Court Munich I on April 17, 2025, in the patent infringement litigation (docket No. 7 O 12401/24 and 7 O 12476/24) against Kuraray Europe GmbH (hereinafter referred to as 'Kuraray Europe'), a subsidiary of Kuraray Co., Ltd which we previously announced in the press release dated October 16, 2024, titled 'Filing of Lawsuit Seeking Injunction and Damages for Patent Infringement in Relation to PVB Interlayer in Germany.' Article content Article content This judgments found that the sound-insulating wedge products manufactured and sold by Kuraray Europe, namely ''Trosifol' The Wedge Acoustic' and ''Trosifol' The Wedge Acoustic Shadeband' (hereinafter collectively referred to as 'Kuraray Products') infringe European Patent No. 2017237 and European Patent No. 3208247 owned by SEKISUI CHEMICAL, which relate to the sound insulation property of a PVB interlayer. Additionally, the Judgments permit SEKISUI CHEMICAL to enforce measures such as a recall in addition to an injunction against the Kuraray Products, provided that SEKISUI CHEMICAL pays a security deposit. Kuraray Europe may appeal the Judgments. Article content SEKISUI CHEMICAL Group regards its intellectual property rights as an important management resource. It will continue to take strict action in cases where it determines that our intellectual property rights have been infringed. Article content Headquartered in Japan, SEKISUI CHEMICAL CO., LTD. (TOKYO: 4204) and its subsidiaries make up the SEKISUI CHEMICAL Group. 26,000 employees in over 156 companies throughout 20 countries and regions aim to contribute to improving the lives of the people of the world and the earth's environment. Thanks to a history of innovation, dedication and a pioneering spirit, SEKISUI CHEMICAL now holds leading positions in its three diverse business divisions as well as top global market share in interlayer film, foam products, conductive particles and more. Article content Article content Article content Article content Article content
Yahoo
21-05-2025
- Business
- Yahoo
SEKISUI CHEMICAL: Victory in German Patent Infringement Lawsuit Concerning PVB Interlayer Films
TOKYO, May 21, 2025--(BUSINESS WIRE)--The High Performance Plastics Company (President : Akira Asano) of SEKISUI CHEMICAL CO., LTD. (President and Representative Director: Keita Kato; hereinafter "SEKISUI CHEMICAL") hereby notifies that it has obtained judgments in its favor (hereinafter referred to as "the Judgments") from the District Court Munich I on April 17, 2025, in the patent infringement litigation (docket No. 7 O 12401/24 and 7 O 12476/24) against Kuraray Europe GmbH (hereinafter referred to as "Kuraray Europe"), a subsidiary of Kuraray Co., Ltd which we previously announced in the press release dated October 16, 2024, titled "Filing of Lawsuit Seeking Injunction and Damages for Patent Infringement in Relation to PVB Interlayer in Germany." This judgments found that the sound-insulating wedge products manufactured and sold by Kuraray Europe, namely "'Trosifol' The Wedge Acoustic" and "'Trosifol' The Wedge Acoustic Shadeband" (hereinafter collectively referred to as "Kuraray Products") infringe European Patent No. 2017237 and European Patent No. 3208247 owned by SEKISUI CHEMICAL, which relate to the sound insulation property of a PVB interlayer. Additionally, the Judgments permit SEKISUI CHEMICAL to enforce measures such as a recall in addition to an injunction against the Kuraray Products, provided that SEKISUI CHEMICAL pays a security Europe may appeal the Judgments. SEKISUI CHEMICAL Group regards its intellectual property rights as an important management resource. It will continue to take strict action in cases where it determines that our intellectual property rights have been infringed. About SEKISUI CHEMICAL Group Headquartered in Japan, SEKISUI CHEMICAL CO., LTD. (TOKYO: 4204) and its subsidiaries make up the SEKISUI CHEMICAL Group. 26,000 employees in over 156 companies throughout 20 countries and regions aim to contribute to improving the lives of the people of the world and the earth's environment. Thanks to a history of innovation, dedication and a pioneering spirit, SEKISUI CHEMICAL now holds leading positions in its three diverse business divisions as well as top global market share in interlayer film, foam products, conductive particles and more. View source version on Contacts SEKISUI CHEMICAL CO., Communication DepartmentEmail: kouhou@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
